Patient Selection
tumor
ONCOLOGY, TUMOR
Patients with a local, locally advanced, or metastatic solid tumor of at least 10 mm were eligible. Important exclusion criteria were an Eastern Cooperative Oncology Group score higher than 2, estimated glomerular filtration rate below 50 mL/min/1.73 mAfter a major power outage that occurred shortly after injection of patient 5, PET/CT imaging at preset time points was impossible, resulting in insufficient data. Therefore, the study protocol was amended to include 7 instead of 6 patients. Data from 7 subjects were available for evaluation of safety and tolerability; data from 6 subjects were available for evaluation of biodistribution, dosimetry, and tumor uptake.